Company Filing History:
Years Active: 2006
Title: Roger Clive Moses: Innovator in Anti-inflammatory Medications
Introduction
Roger Clive Moses is a notable inventor hailing from Wadebridge, Great Britain. He has made significant contributions to the field of pharmaceuticals, particularly focusing on anti-inflammatory agents. His innovations reflect a deep understanding of medicinal chemistry and the biochemistry of inflammatory processes.
Latest Patents
Moses holds one patent that is quite impactful: the invention of 2,4,5-trisubstituted thiazolyl derivatives and their anti-inflammatory activity. This patent involves the use of compounds designed to combat diseases mediated through TNF-α and/or IL-12. The specificity and complexity of the compound's formula (I) highlight the innovation and research involved in developing these potential therapeutic agents.
Career Highlights
Roger Clive Moses is associated with Janssen Pharmaceutica NV, a prominent company dedicated to pharmaceutical development. His work focuses on creating effective medications that target inflammatory diseases, contributing greatly to advancements in healthcare and treatment options.
Collaborations
Moses has collaborated with noteworthy individuals in the research community, including Christopher John Love and Jean Pierre Frans Van Wauwe. These partnerships illustrate the collaborative nature of innovation in the pharmaceutical field, allowing for the sharing of knowledge and expertise that drives successful outcomes.
Conclusion
In summary, Roger Clive Moses stands out as an inventor making strides in the field of anti-inflammatory medications. His patent and collaborative efforts reflect his commitment to advancing medical science and providing innovative solutions for combating inflammatory diseases. Through his work at Janssen Pharmaceutica, Moses continues to impact the pharmaceutical landscape positively and enhance patient care.